By Professor Alison Ritter

Journal articles

Shanahan M; Seddon J; Ritter A; De Abreu Lourenco R, 2020, 'Valuing families' preferences for drug treatment: a discrete choice experiment', Addiction, 115, pp. 690 - 699, http://dx.doi.org/10.1111/add.14816

O'Keefe D; Ritter A; Stoove M; Hughes C; Dietze P, 2020, 'Harm reduction programs and policy in Australia: Barriers and enablers to effective implementation', Sucht, 66, pp. 33 - 43, http://dx.doi.org/10.1024/0939-5911/a000641

Mellor R; Ritter A, 2020, 'Redressing responses to the treatment gap for people with alcohol problems: The overlooked role of untreated remission from alcohol problems', Sucht, 66, pp. 21 - 30, http://dx.doi.org/10.1024/0939-5911/a000640

Rhodes T; Ritter A, 2020, 'Editing the International Journal of Drug Policy', International Journal of Drug Policy, 76, pp. 102664, http://dx.doi.org/10.1016/j.drugpo.2020.102664

van de Ven K; Ritter A; Berends L; Chalmers J; Lancaster K, 2020, 'Perceptions of purchasing and payment mechanisms in alcohol and other drug treatment services in Australia: A qualitative study involving alcohol and other drug service providers and purchasers of treatment', Drug and Alcohol Review, 39, pp. 189 - 197, http://dx.doi.org/10.1111/dar.13027

van de Ven K; Ritter A; Roche A, 2020, 'Alcohol and other drug (AOD) staffing and their workplace: examining the relationship between clinician and organisational workforce characteristics and treatment outcomes in the AOD field', Drugs Education Prevention and Policy, 27, pp. 1 - 14, http://dx.doi.org/10.1080/09687637.2019.1622649

Ritter A, 2020, 'Making drug policy in summer—drug checking in Australia as providing more heat than light', Drug and Alcohol Review, 39, pp. 12 - 20, http://dx.doi.org/10.1111/dar.13018

Greer A; Ritter A, 2020, 'The legal regulation of drugs and role of government: Perspectives from people who use drugs', Drug and Alcohol Dependence, 206, pp. 107737, http://dx.doi.org/10.1016/j.drugalcdep.2019.107737

Greer A; Ritter A, 2019, 'Harm reduction and the opioid crisis: Emerging policy challenges', International Journal of Drug Policy, 71, pp. 139 - 141, http://dx.doi.org/10.1016/j.drugpo.2019.05.015

Strang J; McDonald R; Campbell G; Degenhardt L; Nielsen S; Ritter A; Dale O, 2019, 'Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine', Drugs, 79, pp. 1395 - 1418, http://dx.doi.org/10.1007/s40265-019-01154-5

Mellor R; Lancaster K; Ritter A, 2019, 'Systematic review of untreated remission from alcohol problems: Estimation lies in the eye of the beholder', Journal of Substance Abuse Treatment, 102, pp. 60 - 72, http://dx.doi.org/10.1016/j.jsat.2019.04.004

Lancaster K; Rhodes T; valentine K; Ritter A, 2019, 'A ‘promising tool’? A critical review of the social and ethico-political effects of wastewater analysis in the context of illicit drug epidemiology and drug policy', Current Opinion in Environmental Science and Health, 9, pp. 85 - 90, http://dx.doi.org/10.1016/j.coesh.2019.06.006

Belackova V; Salmon AM; Day CA; Ritter A; Shanahan M; Hedrich D; Kerr T; Jauncey M, 2019, 'Drug consumption rooms: A systematic review of evaluation methodologies', Drug and Alcohol Review, 38, pp. 406 - 422, http://dx.doi.org/10.1111/dar.12919

Greer AM; Ritter A, 2019, '“It's about bloody time”: Perceptions of people who use drugs regarding drug law reform', International Journal of Drug Policy, 64, pp. 40 - 46, http://dx.doi.org/10.1016/j.drugpo.2018.12.006

Ritter A; van de Ven K, 2019, 'Alcohol and other drug treatment commissioning and purchasing: Is it health care or social-welfare?', Drug and Alcohol Review, 38, pp. 119 - 122, http://dx.doi.org/10.1111/dar.12871

Ritter A; van de Ven K, 2019, 'Is health or social welfare the right question? Response to commentaries', Drug and Alcohol Review, 38, pp. 129 - 130, http://dx.doi.org/10.1111/dar.12900

Ritter A; Mellor R; Chalmers J; Sunderland M; Lancaster K, 2019, 'Key Considerations in Planning for Substance Use Treatment: Estimating Treatment Need and Demand', Journal of Studies on Alcohol and Drugs, 2019, pp. 22 - 30, http://dx.doi.org/10.15288/jsads.2019.s18.22

Ritter A; Chalmers J; Gomez M, 2019, 'Measuring Unmet Demand for Alcohol and Other Drug Treatment: The Application of an Australian Population-Based Planning Model', Journal of Studies on Alcohol and Drugs, 2019, pp. 42 - 50, http://dx.doi.org/10.15288/jsads.2019.s18.42

Lancaster K; Ritter A; valentine K; Rhodes T, 2019, '"A more accurate understanding of drug use": A critical analysis of wastewater analysis technology for drug policy', International Journal of Drug Policy, 63, pp. 47 - 55, http://dx.doi.org/10.1016/j.drugpo.2018.10.011

Tait RJ; Whetton S; Shanahan M; Cartwright K; Ferrante A; Gray D; Kaye S; McKetin R; Pidd K; Ritter A; Roche A; Allsop S, 2018, 'Quantifying the societal cost of methamphetamine use to Australia', International Journal of Drug Policy, 62, pp. 30 - 36, http://dx.doi.org/10.1016/j.drugpo.2018.08.015

Lancaster K; Ritter A; Diprose R, 2018, 'Recasting Participation in Drug Policy', Contemporary Drug Problems, 45, pp. 351 - 365, http://dx.doi.org/10.1177/0091450918776024

Nielsen S; Kowalski M; Wood P; Larney S; Bruno R; Shanahan M; Lenton S; Dietze P; Green T; Murnion B; Ritter A, 2018, 'Routine opioid outcome monitoring in community pharmacy: Pilot implementation study protocol.', Res Social Adm Pharm, http://dx.doi.org/10.1016/j.sapharm.2018.10.024

Ritter A; Hughes CE; Lancaster K; Hoppe R, 2018, 'Using the Advocacy Coalition Framework and Multiple Streams policy theories to examine the role of evidence, research and other types of knowledge in drug policy', Addiction, 113, pp. 1539 - 1547, http://dx.doi.org/10.1111/add.14197

Ritter A; Lancaster K; Diprose R, 2018, 'Improving drug policy: The potential of broader democratic participation', International Journal of Drug Policy, 55, pp. 1 - 7, http://dx.doi.org/10.1016/j.drugpo.2018.01.016

Vuong T; Ritter A; Shanahan M; Ali R; Nguyen N; Pham K; Vuong TTA; Le GM; Vuong T, 2018, 'Outcomes of compulsory detention compared to community-based voluntary methadone maintenance treatment in Vietnam', Journal of Substance Abuse Treatment, 87, pp. 9 - 15, http://dx.doi.org/10.1016/j.jsat.2018.01.011

Barratt MJ; Bruno R; Ezard N; Ritter A, 2018, 'Pill testing or drug checking in Australia: Acceptability of service design features', Drug and Alcohol Review, 37, pp. 226 - 236, http://dx.doi.org/10.1111/dar.12576

McSweeney T; Hughes C; Ritter A, 2018, 'The impact of compliance with a compulsory model of drug diversion on treatment engagement and reoffending', Drugs Education Prevention and Policy, 25, pp. 56 - 66, http://dx.doi.org/10.1080/09687637.2016.1219695

Belackova V; Shanahan M; Ritter A, 2018, 'Mapping regulatory models for medicinal cannabis: A matrix of options', Australian Health Review, 42, pp. 403 - 411, http://dx.doi.org/10.1071/AH16257

Seear K; Lancaster K; Ritter A, 2017, 'A new framework for evaluating the potential for drug law to produce stigma: Insights from an australian study', Journal of Law Medicine and Ethics, 45, pp. 596 - 606, http://dx.doi.org/10.1177/1073110517750599

Lancaster K; Seear K; Ritter A, 2017, 'Making medicine; producing pleasure: A critical examination of medicinal cannabis policy and law in Victoria, Australia', International Journal of Drug Policy, 49, pp. 117 - 125, http://dx.doi.org/10.1016/j.drugpo.2017.07.020

Vuong T; Ritter A; Nguyen N; Ali R, 2017, 'Strengthening advocacy efforts with empirical evidence: A case example of the conduct, uptake and utilisation of research in drug policy decision-making in Vietnam', International Journal of Drug Policy, 49, pp. 41 - 47, http://dx.doi.org/10.1016/j.drugpo.2017.07.029

Bright D; Greenhill C; Britz T; Ritter A; Morselli C, 2017, 'Criminal network vulnerabilities and adaptations', Global Crime, 18, pp. 424 - 441, http://dx.doi.org/10.1080/17440572.2017.1377614

Lancaster K; Hughes C; Ritter A, 2017, '‘Drug dogs unleashed’: An historical and political account of drug detection dogs for street-level policing of illicit drugs in New South Wales, Australia', Australian and New Zealand Journal of Criminology, 50, pp. 360 - 378, http://dx.doi.org/10.1177/0004865816642826

Lancaster K; Treloar C; Ritter A, 2017, '‘Naloxone works’: The politics of knowledge in ‘evidence-based’ drug policy', Health United Kingdom, 21, pp. 278 - 294, http://dx.doi.org/10.1177/1363459316688520

Hughes CE; Ritter A; Lancaster K; Hoppe R, 2017, 'Understanding policy persistence – the case of police drug detection dog policy in NSW, Australia', International Journal of Drug Policy, 44, pp. 58 - 68, http://dx.doi.org/10.1016/j.drugpo.2017.03.007

Ritter A; Sotade O, 2017, 'Explaining the declining rates of past year cannabis use in Australia: A first pass', Drug and Alcohol Review, 36, pp. 602 - 608, http://dx.doi.org/10.1111/dar.12553

Ritter A; Stevens A, 2017, 'Improving knowledge on law enforcement in drug policy', International Journal of Drug Policy, 41, pp. 89 - 90, http://dx.doi.org/10.1016/j.drugpo.2017.02.001

Moxham-Hall VL; Ritter A, 2017, 'Indexes as a Metric for Drug and Alcohol Policy Evaluation and Assessment', World Medical and Health Policy, 9, pp. 103 - 126, http://dx.doi.org/10.1002/wmh3.218

Hughes CE; Moxham-Hall V; Ritter A; Weatherburn D; MacCoun R, 2017, 'The deterrent effects of Australian street-level drug law enforcement on illicit drug offending at outdoor music festivals', International Journal of Drug Policy, 41, pp. 91 - 100, http://dx.doi.org/10.1016/j.drugpo.2016.12.018

Lancaster K; Seear K; Treloar C; Ritter A, 2017, 'The productive techniques and constitutive effects of ‘evidence-based policy’ and ‘consumer participation’ discourses in health policy processes', Social Science and Medicine, 176, pp. 60 - 68, http://dx.doi.org/10.1016/j.socscimed.2017.01.031

Belackova V; Ritter A; Shanahan M; Hughes CE, 2017, 'Assessing the concordance between illicit drug laws on the books and drug law enforcement: Comparison of three states on the continuum from “decriminalised” to “punitive”', International Journal of Drug Policy, 41, pp. 148 - 157, http://dx.doi.org/10.1016/j.drugpo.2016.12.013

Ritter A; Hoang VP; Cao VL; Shanahan M; Shukla N; Perez P; Farrell M, 2017, 'Modelling heroin careers over 40 years: Social costs', DRUG AND ALCOHOL DEPENDENCE, 171, pp. E177 - E177, http://dx.doi.org/10.1016/j.drugalcdep.2016.08.486

Vuong T; Nguyen N; Le G; Shanahan M; Ali R; Ritter A, 2017, 'The political and scientific challenges in evaluating compulsory drug treatment centers in Southeast Asia', Harm Reduction Journal, 14, pp. 2, http://dx.doi.org/10.1186/s12954-016-0130-1

Barratt MJ; Ritter A, 2017, 'Commentary on Vrolijk et al. (2017): The paradox of the quality control problem', Addiction, 112, pp. 101 - 102, http://dx.doi.org/10.1111/add.13611

Chalmers J; Ritter A; Berends L, 2016, 'Estimating met demand for alcohol and other drug treatment in Australia', Addiction Abingdon England, 111, pp. 2041 - 2049, http://dx.doi.org/10.1111/add.13473

Ritter A; Hull P; Berends L; Chalmers J; Lancaster K, 2016, 'A conceptual schema for government purchasing arrangements for Australian alcohol and other drug treatment', Addictive Behaviors, 60, pp. 228 - 234, http://dx.doi.org/10.1016/j.addbeh.2016.04.017

Berends L; Ritter A; Chalmers J, 2016, 'Collaborative Governance in the Reform of Western Australia's Alcohol and Other Drug Sector', Australian Journal of Public Administration, 75, pp. 137 - 148, http://dx.doi.org/10.1111/1467-8500.12154

Rhodes T; Stevens A; Ritter A; Decorte T, 2016, 'Advancing the science, methods and practices of drug policy research', International Journal of Drug Policy, 31, pp. 1 - 3, http://dx.doi.org/10.1016/j.drugpo.2016.04.010

Ritter A; Livingston M; Chalmers J; Berends L; Reuter P, 2016, 'Comparative policy analysis for alcohol and drugs: Current state of the field', International Journal of Drug Policy, 31, pp. 39 - 50, http://dx.doi.org/10.1016/j.drugpo.2016.02.004

Lancaster K; Ritter A, 2016, 'Erratum: Corrigendum to “Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985–2010” (International Journal of Drug Policy (2014) 25(1) (81–87) (S0955395913001175) (10.1016/j.drugpo.2013.07.002))', International Journal of Drug Policy, 31, pp. 205, http://dx.doi.org/10.1016/j.drugpo.2016.02.017

Back to profile page